#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant neoplasm of choroid Pyruvate dehydrogenase complex deficiency Follicular lymphoma Brain abscess Hypergammaglobulinaemia benign monoclonal Squamous cell carcinoma of the hypopharynx Complex regional pain syndrome Antisynthetase syndrome Alagille syndrome Glioblastoma multiforme Cholangiocarcinoma Short-bowel syndrome Depression Tuberous sclerosis complex Philadelphia chromosome positive More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Ornithine transcarbamoylase deficiency Primary biliary cholangitis Pleural mesothelioma malignant – Treatment Behcet’s syndrome – Trials in Disease Lymphangioma – Diagnostics Leiomyosarcoma recurrent VEXAS syndrome – Diagnostics Fragile X syndrome – Diagnostics Hereditary hypophosphataemic rickets – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Carbonate Rct2100 Pegvaliase Ioflupane (123I) 20-HYDROXYECDYSONE Metamizole Anhydrous Cholestyramine PROMESTRIENE Remifentanil Hydrochloride Dimethyl Fumarate Favezelimab Mk-6194 Leriglitazone ATIRMOCICLIB Disulfiram Oleclumab Lidocaine Hydrochloride Tamuzimod Acetate Vgl101 Pf-06480605 More therapies…

    Learn about Your Condition

    Arterial stiffness Glioma Breast cancer stage III Partial lipodystrophy Adrenocortical carcinoma Endometrial cancer Multiple sclerosis relapse Vestibular disorder Coagulopathy Immune-mediated enterocolitis Bronchopulmonary aspergillosis Hypotension Neuroblastoma recurrent Delayed graft function Breast proliferative changes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on How Rabbit Anti-Human Thymocyte Immunoglobulin Helps Prevent Graft-versus-Host Disease in Children and Adults Undergoing Stem Cell Transplants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Stem cell transplant
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on the Effectiveness of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Treatment Failure

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Chlorhexidine Dihydrochloride
    • Imetelstat Sodium
    • Diphenhydramine Hydrochloride
    France Germany

  • Study on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Azacitidine
    France

  • Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    • Mantle cell lymphoma
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Brexucabtagene Autoleucel
    • Ibrutinib
    Italy

  • Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fidanacogene Elaparvovec
    Belgium France Germany Greece Italy Spain +1

  • Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell disease
    France Italy The Netherlands Spain
Previous Page
1 … 80 81 82 83 84 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!